Metastatic Castration-Resistant Prostate Carcinoma

specific

A prostate carcinoma that has spread to other sites and is resistant to castration therapy.

20

Centers

24

Active Trials

Cancer Funding

Top Centers for Metastatic Castration-Resistant Prostate Carcinoma(20)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
70.5
2
NCI Comprehensive
High-Volume Research Center
70.5
3
NCI Comprehensive
High-Volume Research Center
70.5
4
NCI Clinical
High-Volume Research Center
70.5
5
NCI Comprehensive
Active Research Program
48.0
6
NCI Comprehensive
Active Research Program
48.0
7
NCI Comprehensive
Active Research Program
48.0
8
NCI Comprehensive
Active Research Program
48.0
9
NCI Comprehensive
Active Research Program
48.0
1048.0
11
NCI Comprehensive
Active Research Program
48.0
12
NCI Comprehensive
Active Research Program
48.0
13
NCI Comprehensive
Active Research Program
48.0
14
NCI Comprehensive
Active Research Program
48.0
15
NCI Comprehensive
Active Research Program
48.0
16
Active Research Program
48.0
17
NCI Comprehensive
Active Research Program
48.0
18
Active Research Program
48.0
19
Active Research Program
48.0
20
Active Research Program
48.0

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →